CNBC's "Fast Money" podcast

Apple Reports Results… And Novo Nordisk’s Obesity Drug Price Cut 5/2/24

0:00
44:11
Manda indietro di 15 secondi
Manda avanti di 15 secondi

Apple on the move after its results. We’re diving into the numbers and the call from the iPhone maker. Plus shedding the pounds and the prices. Novo Nordisk lowering prices for its blockbuster weight loss drugs. How an increase in competition is tipping the scales in the space.

 

Fast Money Disclaimer

Altri episodi di "CNBC's "Fast Money""